ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
TEMA ONCOLOGY ETF
41.87
+0.3415
0.82%
成交量:
3,062
成交額:
12.81萬
市值:
2.06億
市盈率:
- -
高:
41.95
開:
41.74
低:
41.74
收:
41.53
52周最高:
47.00
52周最低:
26.62
股本:
491.00萬
流通股本:
491.00萬
量比:
0.52
換手率:
0.06%
股息:
0.02
股息率:
0.05%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
生存期幾乎翻倍!BioNTech(BNTX.US)肺癌候選藥PRESERVE-003後期試驗告捷,腫瘤學轉型再獲關鍵支撐
智通财经
·
4小時前
生存期幾乎翻倍!BioNTech(BNTX.US)肺癌候選藥PRESERVE-003後期試驗告捷,腫瘤學轉型再獲關鍵支撐
智通财经
·
4小時前
研究顯示三維腫瘤模型有助加快抗癌藥研發
智通财经
·
昨天
研究顯示三維腫瘤模型有助加快抗癌藥研發
智通财经
·
昨天
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/CANC"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CANC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANC\",,,,,undefined,":{"symbol":"CANC","market":"US","secType":"STK","nameCN":"TEMA ONCOLOGY ETF","latestPrice":41.87,"timestamp":1789397691919,"preClose":41.5285,"halted":0,"volume":3062,"delay":0,"changeRate":0.008223268357874625,"floatShares":4910001,"shares":4910001,"eps":0,"marketStatus":"交易中","change":0.3415,"latestTime":"09-14 10:56:06 EDT","open":41.74,"high":41.95,"low":41.735,"amount":128127.03226,"amplitude":0.005177,"askPrice":41.97,"askSize":600,"bidPrice":41.82,"bidSize":700,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"listingDate":1692158400000,"exchange":"NASDAQ","adjPreClose":41.5285,"sharesOutstanding":4310000,"nav":41.66,"aum":204550600,"dividendRate":0.000468,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":41.47,"preClose":41.5285,"latestTime":"19:30 EDT","volume":13,"amount":539.9995,"timestamp":1789169407821,"change":-0.0585,"changeRate":-0.001409,"amplitude":0},"volumeRatio":0.523242},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANC\",,,,,undefined,":{"symbol":"CANC","floatShares":4910001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.523242,"shares":4910001,"dividePrice":0.0196,"high":41.95,"amplitude":0.005177,"preClose":41.5285,"low":41.735,"week52Low":26.62,"pbRate":"--","week52High":47,"institutionHeld":0,"latestPrice":41.87,"committee":0.076923,"eps":0,"divideRate":0.000468,"volume":3062,"delay":0,"ttmEps":0,"open":41.74,"prevYearClose":34.7203,"prevWeekClose":41.5285,"prevMonthClose":43.3492,"prevQuarterClose":41.24,"fiveDayClose":44.0502,"twentyDayClose":42.6638,"sixtyDayClose":37.4716},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CANC\",params:#limit:5,,,undefined,":[{"date":"2025-12-10","symbol":"CANC","amount":0.0195905,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"TEMA ONCOLOGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-11","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-11"},{"date":"2024-12-11","symbol":"CANC","amount":0.72827,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-11","defaultRemindTime":1733927400000,"name":"TEMA ONCOLOGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-12-11","currency":"USD","dateTimestamp":1733893200000,"payDate":"2024-12-12"},{"date":"2023-12-13","symbol":"CANC","amount":0.149112,"announcedDate":"2023-12-12","type":"dividend","market":"US","newRecordDate":"2023-12-14","defaultRemindTime":1702477800000,"name":"TEMA ONCOLOGY ETF","recordDate":"2023-12-15","payableDate":"2023-12-14","currency":"USD","dateTimestamp":1702443600000,"payDate":"2023-12-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CANC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-13","recordDate":"2023-12-14","paymentDate":"2023-12-15","value":0.149112,"currency":"USD"},{"executeDate":"2024-12-11","recordDate":"2024-12-11","paymentDate":"2024-12-12","value":0.72827,"currency":"USD"},{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-11","value":0.0195905,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CANC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CANC\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667570696","title":"生存期幾乎翻倍!BioNTech(BNTX.US)肺癌候選藥PRESERVE-003後期試驗告捷,腫瘤學轉型再獲關鍵支撐","url":"https://stock-news.laohu8.com/highlight/detail?id=2667570696","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667570696?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:26","pubTimestamp":1789381582,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","BK4551","BK4535","CANC","BK4548","BNTX","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667064657","title":"生存期幾乎翻倍!BioNTech(BNTX.US)肺癌候選藥PRESERVE-003後期試驗告捷,腫瘤學轉型再獲關鍵支撐","url":"https://stock-news.laohu8.com/highlight/detail?id=2667064657","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667064657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:26","pubTimestamp":1789381582,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,BioNTech周一表示,一项后期临床试验显示,其候选药物gotistobart在一种特定类型肺癌中,较标准治疗带来具有临床意义的总生存期获益。公司称,该试验为PRESERVE-003 III期临床试验,纳入的是在接受既往免疫治疗和化疗后疾病仍出现进展的鳞状非小细胞肺癌患者;与标准治疗化疗相比,gotistobart使生存期几乎翻倍。鳞状非小细胞肺癌约占所有肺癌病例的25%至30%,在非小细胞肺癌中属于侵袭性较强的亚型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495746.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BNTX","BK4551","BK4548","BK4585","CANC","BK4588","BK4139","BK4535","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667468184","title":"研究顯示三維腫瘤模型有助加快抗癌藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2667468184","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667468184?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 16:07","pubTimestamp":1789286855,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667868766","title":"研究顯示三維腫瘤模型有助加快抗癌藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2667868766","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667868766?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 12:13","pubTimestamp":1789272804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CANC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CANC\",params:#limit:6,delay:false,,,undefined,":[]}}